[Clinical features of osteoarthritis in patients with metabolic syndrome].

Aim: To estimate clinical and laboratory parameters in patients with osteoarthritis (OA) and in those with OA and metabolic syndrome (MS).

Subjects And Methods: 164 patients with OA were examined and divided into 2 groups of 82 people: a study group (patients with MS) and a control one (those without MS). OA was defined according to the diagnostic criteria described by R.

[PECULIAR CLINICAL FEATURES OF OSTEOPOROSIS IN PATIENTS WITH METABOLIC SYNDROME].

Aim: To study peculiar clinical features of osteoporosis in patients with metabolic syndrome (MS).

Methods: We examined 160 patients with osteoarthrosis divided into 2 groups each containing 80 patients with MS and without it (control). Osteoarthrosis was diagnosed using the R.

[Influence of Artrofoon on the current of the metabolic syndrome in patients with rheumatoid arthritis].

This article shows observable effects of Artrofoon concerning displays a metabolic syndrome in patients with rheumatoid arthritis. Patients of the basic group received Artrofoon throughout 12 months by 4 tablets a day, thus it was possible to reach authentic decrease in level of uric acid, improvement of indicators of a lipid spectrum of blood, weight reduction, to stabilise arterial pressure. Thus, positive influence of the preparation on the basic displays of a metabolic syndrome has been noted.

[Effect of atorvastatin (liptonorm) on indicators of the lipid spectrum of blood in patients with the metabolic syndrome].

In this work the effects of Atorvastatin (liptonorm) in a dosage of 10 mg/24h during 12 months concerning the basic indicators of a lipid spectrum of blood in the patients with a metabolic syndrome are estimated. We have noticed its positive effect concerning not only the general cholesterol and cholesterol lipoproteid of low density, but also concerning thriglicerol and cholesterol lipoproteid of high density, which confirms its favorable influence on the basic indicators of a lipid spectrum in the patients with a metabolic syndrome.